Alexandra Ham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexandra Ham has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Amelia Weber Hall
Broad Institute of MIT Harvard Broad Institute of MIT Harvard
3 shared publications - Charles B. Epstein
Epigenomics Program, Broad Institute of Harvard and MIT, Cambridge, United States of America
3 shared publications Cassandra White
Broad Institute of MIT Harvard Broad Institute of MIT Harvard
2 shared publicationsEugenio Mattei
Broad Institute of MIT Harvard Broad Institute of MIT Harvard
2 shared publicationsGuillermo Barreto Corona
2 shared publications- Gwyneth Torrecampo
Broad Institute of MIT Harvard Broad Institute of MIT Harvard
2 shared publications
Latest Publications
- Open Access
The 9p21.3 Coronary Artery Disease Risk Locus Modulates Vascular Cell-State Transitions via Enhancer-Driven Regulation of MTAP
Summary: The 9p21.3 locus is the strongest genetic association with coronary artery disease (CAD), yet its causal mechanisms remain unresolved. We map the regulatory architecture of 9p21.3 in disease-relevant vascular cells, identifying 12 enhancers within the CAD risk haplotype that respond dynamically to inflammatory and metabolic stress in fibroblasts and smooth muscle cells. These activated states are enriched for CAD heritability, implicating stress-responsive vascular wall cells in disease pathophysiology. Dense CRISPRi tiling integrated with fine-mapping and genomic constraint across >500,000 individuals nominates MTAP as the effector gene, with rs1537371 as a likely causal variant. Perturbation and multi-modal analyses show that MTAP loss induces pro-fibrotic and angiogenic programs and sensitizes vascular cells to TGF- β –driven pathological transitions. Our findings reveal a vascular-specific enhancer network through which noncoding variation at 9p21.3 modulates CAD risk via MTAP —a previously unrecognized regulator of vascular remodeling located 269 kb from the risk haplotype. Highlights: 9p21.3 CAD risk locus harbors 12 functional enhancers active in vascular wall cell types CAD heritability is enriched in stressed vascular fibroblasts and smooth muscle cells High-resolution CRISPRi-MAC-seq maps 9p21.3 enhancer-gene and SNP-gene interactions MTAP identified as a causal effector gene regulated by 9p21.3 fine-mapped and constrained variants MTAP modulates TGF-β-driven pathological vascular cell transitions
Open AccessThe 9p21.3 Coronary Artery Disease Risk Locus Modulates Vascular Cell-State Transitions via Enhancer-Driven Regulation of MTAP
Summary: The 9p21.3 locus is the strongest genetic association with coronary artery disease (CAD), yet its causal mechanisms remain unresolved. We map the regulatory architecture of 9p21.3 in disease-relevant vascular cells, identifying 12 enhancers within the CAD risk haplotype that respond dynamically to inflammatory and metabolic stress in fibroblasts and smooth muscle cells. These activated states are enriched for CAD heritability, implicating stress-responsive vascular wall cells in disease pathophysiology. Dense CRISPRi tiling integrated with fine-mapping and genomic constraint across >500,000 individuals nominates MTAP as the effector gene, with rs1537371 as a likely causal variant. Perturbation and multi-modal analyses show that MTAP loss induces pro-fibrotic and angiogenic programs and sensitizes vascular cells to TGF- β –driven pathological transitions. Our findings reveal a vascular-specific enhancer network through which noncoding variation at 9p21.3 modulates CAD risk via MTAP —a previously unrecognized regulator of vascular remodeling located 269 kb from the risk haplotype. Highlights: 9p21.3 CAD risk locus harbors 12 functional enhancers active in vascular wall cell types CAD heritability is enriched in stressed vascular fibroblasts and smooth muscle cells High-resolution CRISPRi-MAC-seq maps 9p21.3 enhancer-gene and SNP-gene interactions MTAP identified as a causal effector gene regulated by 9p21.3 fine-mapped and constrained variants MTAP modulates TGF-β-driven pathological vascular cell transitions
- Open Access
- 23 June 2023
- Published by Springer Nature
SHARE-seq protocol v2.2 v2
An updated version of the protocol SHARE-seq, as used by the Epigenomics Platform and Gene Regulation Observatory at the Broad Institute in the service of data production for the IGVF project. Link to the original paper and protocol here: https://www.sciencedirect.com/science/article/pii/S0092867420312538
- 23 June 2023
- Published by Springer Nature
Open AccessSHARE-seq protocol v2.2 v2
An updated version of the protocol SHARE-seq, as used by the Epigenomics Platform and Gene Regulation Observatory at the Broad Institute in the service of data production for the IGVF project. Link to the original paper and protocol here: https://www.sciencedirect.com/science/article/pii/S0092867420312538
- Open Access
- 23 June 2023
- Published by Springer Nature
SHARE-seq protocol v2.2 v2
An updated version of the protocol SHARE-seq, as used by the Epigenomics Platform and Gene Regulation Observatory at the Broad Institute in the service of data production for the IGVF project. Link to the original paper and protocol here: https://www.sciencedirect.com/science/article/pii/S0092867420312538
- 23 June 2023
- Published by Springer Nature
Open AccessSHARE-seq protocol v2.2 v2
An updated version of the protocol SHARE-seq, as used by the Epigenomics Platform and Gene Regulation Observatory at the Broad Institute in the service of data production for the IGVF project. Link to the original paper and protocol here: https://www.sciencedirect.com/science/article/pii/S0092867420312538